Wednesday, June 8th, 2016 - WiseGuyReports

Global (Us, Eu, G7 & E7) Fragile X Syndrome Clinical Trials Review H1 2016

Summary adds “Global (Us, Eu, G7 & E7) Fragile X Syndrome Clinical Trials Review H1 2016” report to its research database.

The clinical trial report, “Fragile X Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Fragile X Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Fragile X Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using The proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Complete report in Detailed @


*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides a snapshot of the global clinical trials landscape 
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status 
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company 
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment 
- The Report provides enrollment trends for the past five years 
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment 
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost 
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities 
- Supports understanding of trials count and enrollment trends by country in global therapeutics market 
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials 
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Get 15% Discount and Bundle offer also @


Table of Contents 

Table of Contents 2 
List of Tables 3 
List of Figures 4 
Report Guidance 5 
Clinical Trials by Region 6 
Clinical Trials and Average Enrollment by Country 7 
Top Countries Contributing to Clinical Trials in Asia-Pacific 10 
Top Five Countries Contributing to Clinical Trials in Europe 11 
Top Countries Contributing to Clinical Trials in North America 12 
Top Countries Contributing to Clinical Trials in Middle East and Africa 13 
Top Countries Contributing to Clinical Trials in Central and South America 14 
Clinical Trials by G7 Countries: Proportion of Fragile X Syndrome to Genetic Disorders Clinical Trials 15 
Clinical Trials by Phase in G7 Countries 16 
Clinical Trials in G7 Countries by Trial Status 17 
Clinical Trials by E7 Countries: Proportion of Fragile X Syndrome to Genetic Disorders Clinical Trials 18 
Clinical Trials by Phase in E7 Countries 19 
Clinical Trials by Phase 20 
In Progress Trials by Phase 21 
Clinical Trials by Trial Status 22 
Clinical Trials by End Point Status 23 
Subjects Recruited Over a Period of Time 24 
Clinical Trials by Sponsor Type 25 
Prominent Sponsors 26 
Top Companies Participating in Fragile X Syndrome Therapeutics Clinical Trials 27 
Prominent Drugs 29 
Latest Clinical Trials News on Fragile X Syndrome 30 
Apr 12, 2016: Cannabis and Cannabinoid Research Publishes Data Demonstrating the Degradation of Cannabidiol to Psychoactive Cannabinoids when Exposed to Simulated Gastric Fluid 30 
Mar 08, 2016: Neurotrope Announces Publication Demonstrating Synaptic Regeneration with the PKC epsilon Activator Bryostatin, in a Fragile X Disease Late Brain Development Model 30 
Clinical Trial Profile Snapshots 32 
Appendix 60 
Abbreviations 60 
Definitions 60 
Research Methodology 61 
Secondary Research 61 
About GlobalData 62 
Contact Us 62 
Disclaimer 62 


Sample Page of the Report @


Contact US:                   


Partner Relations & Marketing Manager

[email protected]   

Ph: +1-646-845-9349 (US)      

Ph: +44 208 133 9349 (UK)

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Fragile X Syndrome ,Fragile X Syndrome Industry ,Fragile X Syndrome Market ,Fragile X Syndrome Market Trends, Fragile X Syndrome  Industry Trends, Fragile X Syndrome Market Share, Fragile X Syndrome Market Growth ,Fragile X Syndrome  Market Size, Fragile




More Formats